Ruijia Lai

Ruijia Lai

Auto-generated profile, based on publicly available information

Ruijia Lai

Institute of Molecular Physiology, Shenzhen Bay Laboratory

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MWMenghan Wu
Menghan Wu
PSPeishang Shi
Peishang Shi
JHJianmin Huang
Jianmin Huang
XNXiaomin Ni
Xiaomin Ni
RLRuijia Lai
Ruijia Lai
YZYang Zhang
Yang Zhang
The immunosuppressive tumor microenvironment enables immune evasion through mechanisms beyond canonical immune checkpoints. While phosphatidylserine (PS) externalization coordinates apoptotic clearance under physiological conditions, tumors hijack this mechanism through apoptotic mimicry to subvert antitumor immunity. Here, we identify TMEM16F, a calcium-activated phospholipid scramblase, as a driver of tumor-intrinsic PS externalization. TMEM16F-mediated PS scrambling polarized macrophages to an immunosuppressive M2 phenotype, which promotes TGF-β1 secretion and regulatory T cell expansion to suppress cytotoxic lymphocytes. Genetic ablation of TMEM16F abolished PS exposure, systemically reprogrammed the tumor microenvironment and primary immune organs toward immune activation, and suppressed tumor growth across cancer models. Pharmacological scramblase inhibition produced these effects, demonstrating therapeutic potential. Our findings establish TMEM16F-dependent phospholipid scrambling as a critical immune evasion axis and propose targeting this pathway for cancer treatment.